Enterprise Value
2.528M
Cash
5.696M
Avg Qtr Burn
-4.226M
Short % of Float
1.43%
Insider Ownership
21.90%
Institutional Own.
40.53%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Zagociguat (CY6463) Details Neurological disorder, Alzheimer's disease, Dementia | Phase 2 Update | |
Zagociguat (CY6463) Details Cognitive Impairment Associated with Schizophrenia | Phase 1b Update | |
Praliciguat (sGC stimulator) Details Heart disease | Failed Discontinued | |
Olinciguat Details Sickle cell disease | Failed Discontinued | |
Zagociguat (CY6463) Details Rare diseases, Mitochondrial disease, Rare genetic disease | Failed Discontinued |